| Secondary |
| Product Used For Unknown Indication |
20.4% |
| Hypertension |
14.8% |
| Prophylaxis |
11.1% |
| Hypothyroidism |
9.3% |
| Metastatic Renal Cell Carcinoma |
7.4% |
| Osteoporosis |
5.6% |
| Restless Legs Syndrome |
5.6% |
| Thrombosis |
5.6% |
| Thyroidectomy |
5.6% |
| Drug Use For Unknown Indication |
3.7% |
| Schizophrenia |
3.7% |
| Hypertonia |
1.9% |
| Metastases To Bone |
1.9% |
| Nausea |
1.9% |
| Renal Cancer Metastatic |
1.9% |
|
| Venous Thrombosis |
27.3% |
| Blood Urea Increased |
9.1% |
| Cardiomyopathy |
9.1% |
| Left Atrial Dilatation |
9.1% |
| Left Ventricular Hypertrophy |
9.1% |
| Tension |
9.1% |
| Tricuspid Valve Incompetence |
9.1% |
| Urinary Tract Infection |
9.1% |
| Vertigo |
9.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
15.4% |
| Hypertension |
12.9% |
| Product Used For Unknown Indication |
11.6% |
| Hypothyroidism |
9.3% |
| Colitis Ulcerative |
5.9% |
| Rheumatoid Arthritis |
5.7% |
| Breast Cancer |
5.1% |
| Prophylaxis |
4.9% |
| Depression |
3.1% |
| Type 2 Diabetes Mellitus |
2.8% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Pain |
2.6% |
| Sleep Disorder |
2.6% |
| Anaemia |
2.3% |
| Arthritis |
2.3% |
| Colorectal Cancer Metastatic |
2.3% |
| Osteoporosis |
2.3% |
| Renal Cell Carcinoma |
2.3% |
| Constipation |
2.1% |
| Coronary Artery Disease |
2.1% |
|
| Pneumonia |
12.2% |
| Sarcoma |
8.1% |
| General Physical Health Deterioration |
6.8% |
| Sepsis |
6.8% |
| Tumour Flare |
6.8% |
| Fall |
5.4% |
| Pulmonary Embolism |
5.4% |
| Respiratory Tract Infection |
5.4% |
| Thrombocytopenia |
5.4% |
| Transaminases Increased |
5.4% |
| Pyrexia |
4.1% |
| Sequestrectomy |
4.1% |
| Sleep Disorder |
4.1% |
| Vertigo |
4.1% |
| Electrocardiogram Abnormal |
2.7% |
| Endometrial Disorder |
2.7% |
| Gout |
2.7% |
| Hyperbilirubinaemia |
2.7% |
| Hyponatraemia |
2.7% |
| Infusion Related Reaction |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Drug Interaction |
50.0% |
| Mania |
50.0% |
|
